2 Beaten-Down Stocks Primed for a Comeback
Equity markets are said to be forward looking. However, sometimes they fail to look far enough into the future by reacting too harshly to the challenges some companies face in the present. The good news is that this often creates opportunities for astute investors to pick up shares of great companies with excellent prospects on the dip.
And that's precisely what we have with Novo Nordisk (NYSE: NVO) and Vertex Pharmaceuticals (NASDAQ: VRTX), two leading drugmakers that have significantly lagged the market this year.
Image source: Getty Images.
Source Fool.com
Vertex Pharmaceuticals Inc. Stock
€380.50
1.320%
With 38 Buy predictions and not a single Sell prediction Vertex Pharmaceuticals Inc. is an absolute favorite of our community.
As a result the target price of 460 € shows a positive potential of 20.89% compared to the current price of 380.5 € for Vertex Pharmaceuticals Inc..
